Recent Finacing
Recent Raise
NuProbe develops toehold probe–based molecular diagnostics and ultra‑sensitive NGS and PCR assays for noninvasive cancer, NIPT, and infectious-disease testing, operating labs in Houston, Shanghai, Suzhou, and Cambridge.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at NuProbe.